Cargando…

New Pathological and Clinical Insights in Endometrial Cancer in View of the Updated ESGO/ESTRO/ESP Guidelines

SIMPLE SUMMARY: Histopathological classification of endometrial carcinoma has evidenced two main groups with different biological behavior: low-grade (G1–G2) and high-grade (G3) endometrial tumors. Moreover, the Cancer Genome Atlas (TCGA) documented four molecular categories with distinct clinical,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santoro, Angela, Angelico, Giuseppe, Travaglino, Antonio, Inzani, Frediano, Arciuolo, Damiano, Valente, Michele, D’Alessandris, Nicoletta, Scaglione, Giulia, Fiorentino, Vincenzo, Raffone, Antonio, Zannoni, Gian Franco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198052/ https://www.ncbi.nlm.nih.gov/pubmed/34073635 http://dx.doi.org/10.3390/cancers13112623

Ejemplares similares

Clear cell endometrial carcinoma precursors: presentation of two cases and diagnostic issues
por: Santoro, Angela, et al.
Publicado: (2021)

Endometrial Metaplastic/Reactive Changes Coexistent with Endometrial Hyperplasia and Carcinoma: A Morphological and Immunohistochemical Study
por: Travaglino, Antonio, et al.
Publicado: (2021)

Depth of Stromal Invasion as the Most Prognostically Relevant Regression System in Locally Advanced Cervical Cancer after Neoadjuvant Treatment: A Systematic Review and Meta-Analysis Grading
por: Zannoni, Gian Franco, et al.
Publicado: (2021)

Assessing Post-Treatment Pathologic Tumor Response in Female Genital Tract Carcinomas: An Update
por: Inzani, Frediano, et al.
Publicado: (2022)

Prognostic Value of Chemotherapy Response Score (CRS) Assessed on the Adnexa in Ovarian High-Grade Serous Carcinoma: A Systematic Review and Meta-Analysis
por: Santoro, Angela, et al.
Publicado: (2022)

An Emerging Anti-p16 Antibody-BC42 Clone as an Alternative to the Current E6H4 for Use in the Female Genital Tract Pathological Diagnosis: Our Experience and a Review on p16ink4a Functional Significance, Role in Daily-Practice Diagnosis, Prognostic Potential, and Technical Pitfalls
por: Angelico, Giuseppe, et al.
Publicado: (2021)

Prognostic value of the TCGA molecular classification in uterine carcinosarcoma
por: Travaglino, Antonio, et al.
Publicado: (2021)

Pilomatrix-like High-Grade Endometrioid Carcinoma of the Ovary: Case Report, Literature Review, and Differential Diagnosis
por: Santoro, Angela, et al.
Publicado: (2022)

L1CAM Expression in Microcystic, Elongated, and Fragmented (MELF) Glands Predicts Lymph Node Involvement in Endometrial Carcinoma
por: Arciuolo, Damiano, et al.
Publicado: (2022)

The Role of Plasma Cells as a Marker of Chronic Endometritis: A Systematic Review and Meta-Analysis
por: Santoro, Angela, et al.
Publicado: (2023)

Recent Advances in Cervical Cancer Management: A Review on Novel Prognostic Factors in Primary and Recurrent Tumors
por: Santoro, Angela, et al.
Publicado: (2023)

Diagnostic and Prognostic Role of WT1 Immunohistochemical Expression in Uterine Carcinoma: A Systematic Review and Meta-Analysis across All Endometrial Carcinoma Histotypes
por: Angelico, Giuseppe, et al.
Publicado: (2020)

Biomarker characterization in endometrial cancer in Italy: first survey data analysis
por: Zannoni, Gian Franco, et al.
Publicado: (2022)

Biosafety procedures for handling intraoperative surgical samples during COVID-19 pandemic: an Italian pathology laboratory experience
por: Santoro, Angela, et al.
Publicado: (2020)

Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early‐stage endometrial cancer: A propensity score–matched analysis
por: Nero, Camilla, et al.
Publicado: (2022)

Diagnostic impact of safety protocols for processing peritoneal washing specimens during the global pandemic of coronavirus disease 2019: A comparative study from 195 cytological samples
por: Santoro, Angela, et al.
Publicado: (2021)

Prognostic Value of Mandard’s Tumor Regression Grade (TRG) in Post Chemo-Radiotherapy Cervical Cancer
por: Scaglione, Giulia, et al.
Publicado: (2023)

ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*
por: Cibula, David, et al.
Publicado: (2023)

ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*
por: Cibula, David, et al.
Publicado: (2023)

TCGA Molecular Prognostic Groups of Endometrial Carcinoma: Current Knowledge and Future Perspectives
por: Arciuolo, Damiano, et al.
Publicado: (2022)

Hormonal Environment and HER2 Status in Extra-Mammary Paget’s Disease (eMPD): A Systematic Literature Review and Meta-Analysis with Clinical Considerations
por: Angelico, Giuseppe, et al.
Publicado: (2020)

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up
por: Colombo, Nicoletta, et al.
Publicado: (2016)

What Can Trigger Spontaneous Regression of Breast Cancer?
por: D’Alessandris, Nicoletta, et al.
Publicado: (2023)

Failure of ulipristal acetate treatment as an indication for uterine malignancy: Two case reports
por: Santoro, Angela, et al.
Publicado: (2018)

Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice
por: de Biase, Dario, et al.
Publicado: (2023)

Neuroendocrine Carcinoma of the Uterine Cervix: A Clinicopathologic and Immunohistochemical Study with Focus on Novel Markers (Sst2–Sst5)
por: Inzani, Frediano, et al.
Publicado: (2020)

Primary Mucinous Cystadenocarcinoma of the Breast Intermixed with Pleomorphic Invasive Lobular Carcinoma: The First Report of This Rare Association
por: Vegni, Federica, et al.
Publicado: (2023)

ESGO/ESTRO quality indicators for radiation therapy of cervical cancer
por: Chargari, Cyrus, et al.
Publicado: (2023)

Pathological Chemotherapy Response Score in Patients Affected by High Grade Serous Ovarian Carcinoma: The Prognostic Role of Omental and Ovarian Residual Disease
por: Santoro, Angela, et al.
Publicado: (2019)

Concordance between preoperative ESMO-ESGO-ESTRO risk classification and final histology in early-stage endometrial cancer
por: Daix, Manon, et al.
Publicado: (2021)

Editorial: Future Perspectives of Sentinel Node Mapping in Gynecological Oncology
por: Santoro, Angela, et al.
Publicado: (2022)

Evaluation of Beta-Catenin Subcellular Localization and Water Channel Protein AQP1 Expression as Predictive Markers of Chemo-Resistance in Ovarian High-Grade Serous Carcinoma: Comparative Study between Preoperative Peritoneal Biopsies and Surgical Samples
por: Angelico, Giuseppe, et al.
Publicado: (2021)

Integration of Molecular Data in the Prognostic Stratification and Management of Endometrial Carcinoma
por: Raffone, Antonio, et al.
Publicado: (2022)

Clinical Characteristics of Patients with Endometrial Cancer and Adenomyosis
por: Casadio, Paolo, et al.
Publicado: (2021)

Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: our experience
por: Santoro, A., et al.
Publicado: (2019)

ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma(,)
por: Rodolakis, Alexandros, et al.
Publicado: (2023)

ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma
por: Rodolakis, A, et al.
Publicado: (2023)

Accuracy of cytological examination of Tao brush endometrial sampling in diagnosing endometrial premalignancy and malignancy
por: Raffone, Antonio, et al.
Publicado: (2022)

Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group
por: Zannoni, Gian Franco, et al.
Publicado: (2022)

Impact of adenomyosis on the prognosis of patients with endometrial cancer
por: Raimondo, Diego, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_94mc93ih9d2jestkr0p2s44rv9